Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic
Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The broad objective of this investigation is to assess the safety and efficacy of oral
therapy with dexmedetomidine for the induction and maintenance of restful sleep.